Clinical Trial Update: Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Proellex in premenopausal women with symptomatic uterine fibroids; the trial was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 3 | Status: TERMINATED | Results posted: 2014-08-21